tiprankstipranks
Lipocine (LPCN)
NASDAQ:LPCN
US Market

Lipocine (LPCN) Financial Statements

872 Followers

Lipocine Financial Overview

Lipocine's market cap is currently ―. The company's EPS TTM is $-1.724; its P/E ratio is -4.23; Lipocine is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.78. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 7.62M$ -3.12M-$ 55.00K-
Gross Profit$ 7.62M$ -3.12M-$ 55.00K-
EBIT$ 3.22M$ -6.65M$ -3.55M$ -3.87M$ -2.53M
EBITDA$ 3.23M$ -6.64M$ -3.79M$ -4.12M$ -2.68M
Net Income Common Stockholders$ 3.51M$ -6.65M$ -3.55M$ 4.92M$ -2.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 24.63M$ 23.85M$ 25.79M$ 28.87M$ 32.53M
Total Assets$ 25.45M$ 24.75M$ 30.48M$ 34.02M$ 37.54M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -24.63M$ -23.85M$ -25.79M$ -28.87M$ -32.53M
Total Liabilities$ 1.43M$ 2.27M$ 1.83M$ 1.93M$ 1.91M
Stockholders Equity$ 24.01M$ 22.48M$ 28.66M$ 32.09M$ 35.63M
Cash Flow-
Free Cash Flow$ 2.41M$ -2.61M$ -3.31M$ -3.93M$ -1.94M
Operating Cash Flow$ 2.41M$ -2.61M$ -3.31M$ -3.93M$ -1.84M
Investing Cash Flow$ -4.09M$ 1.24M$ 3.56M$ 5.55M$ 2.60M
Financing Cash Flow$ -8.10K$ 421.08K$ -5.20K$ -6.02K$ -5.90K
Currency in USD

Lipocine Earnings and Revenue History

Lipocine Debt to Assets

Lipocine Cash Flow

Lipocine Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis